Pediatric Interventional Cardiology Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Pediatric Interventional Cardiology Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Pediatric Interventional Cardiology Market:

https://www.thebusinessresearchcompany.com/report/pediatric-interventional-cardiology-global-market-report

According to The Business Research Company’s Pediatric Interventional Cardiology Global Market Report 2024, The pediatric interventional cardiology market size has grown strongly in recent years. It will grow from $2.31 billion in 2023 to $2.51 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The  growth in the historic period can be attributed to increased mycotoxin awareness, stringent regulatory standards, focus on animal health, globalization of poultry production, market competitiveness, increased farm productivity..

The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.34 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing poultry industry, climate change impacts, demand for organic products, global trade dynamics, government initiatives, increasing health consciousness.. Major trends in the forecast period include integration of technology, feed quality and safety, market consolidation, collaborative research efforts, digitalization in agriculture, advancements in feed technology..

The increasing prevalence of congenital heart disease is expected to propel the growth of the pediatric interventional cardiology market. Congenital heart disease is any problem that has affected the heart and its structure since birth. Pediatric interventional cardiology procedures are used to treat congenital heart disease that advantages over traditional open-heart surgery, including shorter recovery times, reduced risk of infection, and less scarring. For instance, in 2022, according to the American Heart Association, a US-based non-profit organization that is focused on cardiovascular medical research, approximately 40,000 infants in the United States are affected by congenital heart defects, and the birth prevalence of congenital heart diseases is estimated to be 12.3 per 1000 in the country. Furthermore, The Lancet, a weekly peer-reviewed general medical journal based in the United Kingdom, published an article in 2022 stating that congenital heart disease is the most common birth defect, affecting nearly 9 out of every 1000 live births. Therefore, the increasing prevalence of congenital heart disease will drive the growth of the pediatric interventional cardiology market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10384&type=smp

The pediatric interventional cardiology market covered in this report is segmented –

1) By Device Type: Closure Devices, Trans catheter Heart Valves, Atherectomy Devices, Catheters, Balloons, Stents, Other Device Types

2) By Procedure: Catheter-Based Valve Implantation, Congenital Heart Defect Correction, Angioplasty, Coronary Thrombectomy, Other Procedures

3) By End-Use: Clinical Testing Laboratories, Hospitals, Cardiac Centers, Pediatric Clinics, Research Institutions

Product innovation is a key trend in the pediatric interventional cardiology market. Major companies in pediatric interventional cardiology are introducing new and innovative solutions to strengthen their position in the market. For instance, in February 2023, Medtronic plc., a US-based medical devices company launched a trans catheter pulmonary valve, the Harmony Transcatheter Pulmonary Valve System. The Harmony TPV system is a minimally invasive alternative to open-heart surgery and can be implanted through a small incision in the leg or neck. The Harmony TPV system is intended for patients who have previously undergone surgery for congenital heart disease and have a dysfunctional RVOT (right ventricular outflow tract) due to a previously implanted conduit or bio prosthetic pulmonary valve. It is also indicated for patients with native or patched RVOT who require pulmonary valve replacement.

The pediatric interventional cardiology market report table of contents includes:

 

1. Executive Summary
2. Pediatric Interventional Cardiology Market Characteristics
3. Pediatric Interventional Cardiology Market Trends And Strategies
4. Pediatric Interventional Cardiology Market – Macro Economic Scenario
5. Global Pediatric Interventional Cardiology Market Size and Growth

.

.

.

31. Global Pediatric Interventional Cardiology Market Competitive Benchmarking
32. Global Pediatric Interventional Cardiology Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Pediatric Interventional Cardiology Market
34. Pediatric Interventional Cardiology Market Future Outlook and Potential Analysis
35. Appendix

Top Major Players:

• Medtronic PLC
• Abbott Laboratories
• Cardinal Health Inc
• Terumo Corporation
• L. Gore & Associates Inc

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

 

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company  

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ  

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/  

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model